Accepted: 31 December 2021
First Online: 31 January 2022
: This study was deemed exempt from human subjects review by both the Washington State and Oregon Health Sciences University IRBs.
: Data in this study is deidentified and not linked to human subjects.
: Author TK has funding from the Substance Abuse and Mental Health Services, and the US Health Resources and Services for curriculum development and research specific to controlled substance prescribing and safety. Author DH is a paid consultant for the National Multiple Sclerosis Society and has current research funding from the Agency for Health Quality, Centers for Disease Control and National Institute on Drug Abuse for controlled substance prescribing and safety research. Author SK has no disclosures.